Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical...
Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite...
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for...
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research...
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023....
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of...
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET....
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The...
Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at...
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third...
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37%...
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter...
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023....
Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company...
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also...
Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period...
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The...
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced third-quarter 2023 earnings results, reporting a sharp increase in revenues...
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its chief scientist, Jonathan Kurtis MD, PhD has received the...
Intuitive Surgical, Inc. (NASDAQ: ISRG) produces and sells some of the most advanced robotic surgical systems that make medical procedures...
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the third quarter of 2023, reporting higher revenues...
